Cytomegalovirus Avidity Control BR109AVID

$180.00

Summary

Virion/Serion Immunologics reagent for research use (RUO)
Cytomegalovirus (CMV)
Suitable for: ELISA
For use with SERION ELISA classic assays as a CONTROL when determining sample antibody avidity
Reconstitute (refer to COA)

SKU: BR109AVID Categories: avidity reagent, Virion/Serion kits Tags: Cytomegalovirus, ELISA avidity reagent

Weight	1 lbs
Dimensions	9 × 5 × 2 in
target	Cytomegalovirus
species reactivity	Cytomegalovirus
applications	avidity test, ELISA
assay type	Indirect & quantitative
available size	lyophilized

Cytomegalovirus Avidity Control BR109AVID

kit
Research area Infectious Disease
Storage Store at 2 - 8°C until expiration on packaging.
Form ready
Associated products Cytomegalovirus Avidity Reagent (B109AVID) Cytomegalovirus Avidity Control(BR109AVID) Cytomegalovirus Antigen (BA109VS) Cytomegalovirus Avidity Control(BR109AVID) Cytomegalovirus Antigen (BA109VS) Cytomegalovirus IgG Control Serum (BC109G) Cytomegalovirus IgM Control Serum (BC109M) Cytomegalovirus IgG ELISA Kit (ESR109G) Cytomegalovirus IgM ELISA Kit (ESR109M)

target relevance

human antibody anti-Cytomegalovirus (CMV)

Cytomegalovirus (CMV)

Description
Virus that causes cytomegalovirus infection and congenital CMV disease

Structure
Cytomegalovirus (CMV), also known as Human herpesvirus 5 (HHV-5), is an enveloped, double-stranded DNA virus belonging to the genus Cytomegalovirus within the family Herpesviridae. The virus possesses an icosahedral capsid surrounded by a protein tegument and a lipid envelope containing multiple glycoproteins involved in host cell entry. CMV has one of the largest genomes among human viruses and is capable of infecting a wide variety of cell types including epithelial cells, endothelial cells, fibroblasts, monocytes, and leukocytes. Following primary infection, CMV establishes lifelong latency, primarily within cells of the myeloid lineage, and may periodically reactivate, particularly in immunocompromised individuals. CMV is widely distributed throughout the world, and a large proportion of adults show evidence of prior infection.

Diagnosis
The diagnosis of cytomegalovirus infection is performed through serological, molecular, and virological methods. Detection of CMV-specific IgM and IgG antibodies by ELISA or other immunoassays is commonly used to determine recent or past infection. Molecular methods such as quantitative polymerase chain reaction (PCR) are highly sensitive and are widely used to detect and monitor CMV DNA in blood, urine, saliva, cerebrospinal fluid, and other clinical specimens. Antigenemia assays and viral culture may also be employed in selected clinical settings. In pregnant women and immunocompromised patients, laboratory testing is particularly important for assessing active infection, viral load, and risk of disease progression.

Symptoms
Most cytomegalovirus infections in healthy individuals are asymptomatic or cause mild, self-limiting illness resembling infectious mononucleosis, characterized by fever, fatigue, malaise, sore throat, lymphadenopathy, and muscle aches. Following primary infection, the virus remains latent and may reactivate later in life. In immunocompromised individuals, including transplant recipients, cancer patients, and people with advanced HIV infection, CMV can cause severe disease involving the lungs, liver, gastrointestinal tract, retina, and central nervous system. Congenital CMV infection is a major cause of birth defects and may result in hearing loss, vision impairment, developmental delays, microcephaly, seizures, and other neurological complications. CMV remains one of the most significant opportunistic viral pathogens worldwide.

Data

FAQ & Publications

Frequently Asked Questions

What is the primary application of the Cytomegalovirus Avidity Control BR109AVID?

The Cytomegalovirus Avidity Control BR109AVID is used as a control reagent in ELISA assays to determine the avidity of antibodies against Cytomegalovirus (CMV).

Which species does the Cytomegalovirus Avidity Control BR109AVID target?

This product specifically targets Cytomegalovirus, particularly human CMV (human betaherpesvirus 5).

How should the Cytomegalovirus Avidity Control BR109AVID be stored to maintain stability?

The reagent should be stored at 2 to 8°C until the expiration date indicated on the packaging to ensure its stability and performance.

Is the Cytomegalovirus Avidity Control BR109AVID compatible with specific ELISA kits?

Yes, it is intended for use with SERION ELISA classic assays as a control when determining sample antibody avidity for CMV.

In what form is the Cytomegalovirus Avidity Control BR109AVID supplied?

The product is supplied in a lyophilized form requiring reconstitution prior to use, according to the certificate of analysis instructions.

Publications

pmid	title	authors	citation
We haven't added any publications to our database yet.

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.